Courtenay Brinckerhoff is a partner and intellectual property lawyer with Foley & Lardner LLP. Ms. Brinckerhoff’s practice focuses on client counseling in all aspects of obtaining, licensing and enforcing patents and conducting freedom-to-operate and due diligence investigations. She is chair of the firm’s IP Law and Practice committee, immediate past vice chair of the firm’s Chemical, Biotechnology & Pharmaceutical Practice and a member of the firm's Patent Trials group, Appellate Practice and Life Sciences Industry Team. She also is involved with Foley’s Medical Device Initiative and Nutraceuticals Team. Ms. Brinckerhoff is the editor and primary author for Foley’s PharmaPatentsBlog.com.
Over the past 20 years, Ms. Brinckerhoff has represented clients before the U.S. Patent Office, the Patent Trial and Appeal Board, and the U.S. Court of Appeals for the Federal Circuit, and has been involved in complex patent matters, including a four-party interference, Inter Partes Reexaminations, Inter Partes Reviews, and ANDA litigation.
Ms. Brinckerhoff works with clients in diverse industries, including pharmaceuticals (chemical and biotechnological), human and animal food products, nutraceuticals, and medical devices. She has particular experience with transdermal pharmaceutical products (patches, gels, and liquids), oral dosage forms (including controlled/extended release formulations), enzyme-based technologies, diagnostic and therapeutic antibodies, active and passive immunization therapies, and personalized medicine.
She has served as vice chair of the firm’s Chemical, Biotechnology & Pharmaceutical Practice and is an active member of the firm's Appellate Practice and Life Sciences Industry Team.
More Legal and Business Bylines From Courtenay C. Brinckerhoff
- USPTO Offers Small Entities One Streamlined Patent Appeal - (Posted On Thursday, September 17, 2015)
- Improving Patent Quality With International Collaborative Search Pilot Programs - (Posted On Tuesday, September 15, 2015)
- Patent Trial and Appeal Board Boots Bass Tecfidera IPR On The Merits - (Posted On Tuesday, September 08, 2015)
- Federal Circuit Court Finds Dow Claims Clearly Indefinite - (Posted On Thursday, September 03, 2015)
- Parsing USPTO Petitions Data - (Posted On Tuesday, September 01, 2015)
- Amgen And Apotex Do The Biosimilar Patent Dance - (Posted On Thursday, August 27, 2015)
- PTAB Denies Institution Of Kyle Bass's Ampyra Patent Challenge - (Posted On Tuesday, August 25, 2015)
- Federal Circuit Expands Direct Divided Infringement - (Posted On Thursday, August 20, 2015)
- Sequenom Seeks Rehearing En Banc - (Posted On Tuesday, August 18, 2015)
- Value Of Prophetic Examples re: Lumigan Patent Claims - (Posted On Thursday, August 13, 2015)
Courtenay C. Brinckerhoff and her work on Foley & Lardner's Pharma Patents blog has been selected for a National Law Review Go-To Thought Leadership Award. Ms. Brinckerhoff offers expert analysis on an area of law that can be very complicated, breaking down developments at the U.S. Patent Office, the Patent Trial and Appeal Board, and the U.S. Court of Appeals for the Federal Circuit. Her insights on patent litigation, especially pharmaceutical patents, and how decisions impact the larger landscape are of particular interest to our readers. You can subscribe to Foley & Lardner's blog, PharmaPatents, here.